Our role in diabetes care

Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines.

Being a global leader in integrated Personalised Diabetes Management (iPDM), Roche Diabetes Care aims to transform and advance care provision and foster sustainable care structures.

iPDM is a structured and value-based therapy approach enabled by digital solutions designed to improve therapy outcomes in diabetes.

We develop solutions to facilitate personalised care for all people with diabetes wherever they may be in their diabetes journey, whilst ensuring they remain the focus of our approach.

Our diabetes products

Accu-Chek offers people with diabetes and healthcare professionals innovative and impactful solutions for convenient, efficient and effective diabetes management. It encompasses blood glucose meters, insulin delivery systems and lancing devices that help reduce the hassles of day-to-day diabetes management and contribute to improved outcomes.

The mySugr app was created by people with diabetes for people with diabetes. mySugr gives people with diabetes the tools, know-how, and confidence to manage their diabetes therapy and health outcomes, making it quick and easy to collect relevant therapy data in one place through a growing number of connected devices, integrations, and manual entry.

At Roche Diabetes Care, we pioneer products, solutions and services to help strengthen the patient care process. An open ecosystem supports our iPDM approach by allowing broad connectivity between own and partner devices. By integrating digital solutions that quickly turn data into meaningful insights, we help facilitate stronger collaboration between patients and healthcare professionals for more timely treatment decisions.

M-GB-00011730 Date of Preparation March 2023

More stories

See all stories

Discover more

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationsOur medicinesOur role in pharmaOur role in testing & diagnosticsRoche careersStoriesPrivacy policyTerms & ConditionsModern Slavery Act